People with HIV still running out of treatment options – not always because of resistance
Top 5 HIV treatment stories from CROI 2022
Lenacapavir shows continued promise for first-line treatment and highly resistant HIV
New cases of multi-drug resistant HIV becoming rarer in Europe
Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy
Heavily treatment-experienced people in Europe do not have a higher risk of clinical events
HIV capsid inhibitor offers new option for people with highly resistant HIV
Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade
Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity
